Dr. Marc John Inglese, MD

Dr. Inglese practices at Dermatology Associates of Tallahassee PA in Tallahassee, Florida.

Dr. Inglese's NPI, 1467698159, was assigned on December 30, 2008. Dr. Inglese graduated from University Of Florida College Of Medicine in 2003. Dr. Inglese holds Florida license ME103501.

Dr. Inglese's primary practice is Dermatology Associates of Tallahassee PA, at 1707 Riggins Rd, Tallahassee, FL 32308 in Leon County. The practice phone is (850) 877-4134.

Dr. Inglese's primary practice is Dermatology Associates of Tallahassee PA in Tallahassee, Florida. The medical group on file is Dermatology Associates of Tallahassee. Dmand AI also links Dr. Inglese to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Inglese practices. Vendor and product names are available with a free account.

Dermatology is Dr. Inglese's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Inglese is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Inglese's licenses on file in 4 states: Florida, Georgia, Texas and North Carolina.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and facial skin infection among the conditions Dr. Inglese treats.

CMS data shows 10,076 Medicare services from Dr. Inglese across 36 procedure codes in 2024, for 1,077 Medicare patients. Medicare paid $1,279,343 for them. Every service was in an office.

CMS counts 1,077 Medicare patients who saw Dr. Inglese in 2024. The largest group is 65 to 74, with 449 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Inglese's median patient age at 71, with 51% women.

In 2024, Dr. Inglese wrote 1,425 Medicare Part D claims for 543 patients. 68% of them were for generic drugs. CMS names the drug for 1,296 of them, across 23 drugs with 11 or more claims each, at $3,789,667 in total drug cost. In 2023, CMS named 1,278 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Inglese for performance year 2024, reported as part of a group. Dr. Inglese accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 557 procedures of melanoma (skin cancer) excision by Dr. Inglese, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Inglese. Dr. Inglese's most frequent co-author is Steven Richard Feldman, MD.

CMS Open Payments shows 1,546 general payments to Dr. Inglese from 43 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 81% of the total. Abbvie Inc. paid the most, $664,838.

Dr. Inglese graduated from University Of Florida College Of Medicine in 2003.

Dr. Inglese is in network with 17 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.